Valuation (43%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | -184.45 | 176.39 |
PEG Ratio (TTM) | -3.46 | -3.05 |
P/S Ratio (TTM) | 3.18 | 8.26 |
P/B Ratio (TTM) | 1.45 | 2.19 |
P/FCF Ratio (TTM) | 12.11 | -83.55 |
Price to 5YR AVG Earnings Ratio | -40.80 | 24.96 |
Price to 5YR AVG FCF Ratio | 15.07 | -270.19 |
Profitability (10%) |
Company | Industry |
---|---|---|
ROA (TTM) | -0.17% | 0.77% |
ROE (TTM) | -0.76% | 1.88% |
Net Profit Margin (TTM) | -1.72% | 7.37% |
ROIC 5YR AVG | 3.71% | 2.53% |
Growth (15%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | -27.86% | -56.51% | -23.60% |
Revenue | -5.30% | 1.49% | 3.07% |
Net Income | -29.77% | -57.45% | -23.06% |
Cash Flow | 7.60% | 1.43% | 0.28% |
Health (39%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 3.40 | 8.10 |
Quick Ratio (TTM) | 3.40 | 8.10 |
D/E Ratio (TTM) | 2.64 | 1.06 |
Interest Coverage (TTM) | 0.54 | 1.92 |
Piotroski F-Score | 5 | 6 |
Altman Z-Score | 0.35 | 2.27 |
LTL to 5YR AVG FCF | 25.65 | -86.18 |
Shares Outstanding Growth 5YR AVG | -0.02% | 5.66% |